Vav2 protein overexpression marks and may predict the aggressive subtype of ductal carcinoma in situ

BACKGROUND: A subset of patients with ductal carcinoma in situ (DCIS) will develop invasive breast cancer (IBC). To date, there are no effective predictive biomarkers for identifying this subset with worse prognosis whose lesions are essentially indistinguishable histologically from those with favor...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, YunQing, Prabakaran, Indira, Wan, Fei, Mitra, Nandita, Furstenau, Dana K, Hung, Rupert K, Cao, Siyuan, Zhang, Paul J, Fraker, Douglas L, Guvakova, Marina A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4362647/
https://www.ncbi.nlm.nih.gov/pubmed/25785189
http://dx.doi.org/10.1186/2050-7771-2-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4362647/
https://www.ncbi.nlm.nih.gov/pubmed/25785189
http://dx.doi.org/10.1186/2050-7771-2-22

Ejemplares similares